SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPHTechnologyEDP ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SOPH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $533.65M
- EPS (TTM)
- -$1.09
- Dividend yield
- None
- 52-week range
- 4.01 – 8.98
- Day range
- 6.16 – 6.88
- Volume / Avg
- 827.65K / 678.76K
- Beta
- —
- Shares outstanding
- 85.66M
52-week range
SOPH stock today
SOPHiA GENETICS SA (SOPH) closed at $6.23 on Nov 20, down 6.74% (-$0.45), versus the S&P 500's 3.70% decline. At this level, SOPH sits in the middle of its 52-week range of $4.01 to $8.98: 30.6% below the high, set on Aug 27, 2026 and 55.6% above the low. SOPH is up 33.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 37.2%.
SOPHiA GENETICS SA has posted a net loss over the last twelve months (EPS of -$1.09), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About SOPHiA GENETICS SA
Company profileSOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.
- Sector
- Technology
- Industry
- EDP Services
- CEO
- Mr. Ross Jordan Muken B.Sc.
- Headquarters
- Rolle
- Employees
- 415
- IPO year
- 2021
- Website
- sophiagenetics.com
Financial highlights
Full financialsIn fiscal 2025, SOPHiA GENETICS SA generated $77.3 million in revenue, up 18.6% from fiscal 2024, its 6th consecutive year of revenue growth. SOPHiA GENETICS SA reported a net loss of $79.0 million, compared with a loss of $62.5 million a year earlier. Gross margin was 67.4% (flat year over year) and operating margin -91.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $77.27M | $65.17M | $62.37M | $47.56M | $40.45M |
| Growth | +18.56% | +4.49% | +31.14% | +17.58% | +42.43% |
| Net income | $-79.00M | $-62.49M | $-78.98M | $-87.45M | $-73.67M |
| EPS (diluted) | $-1.17 | $-0.95 | $-1.22 | $-1.36 | $-1.33 |
Analyst forecast
ForecastConsensus (5 analysts)
strong_buy
Avg. price target
$9.75+56.50%
- Strong buy 0
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $-0.30 vs $-0.13
- Surprise
- -130.77%
SOPH news
All SOPH news- SOPHiA: 3 Key Takeaways for Long-Term InvestorsNasdaq
- SOPHiA GENETICS SA Reports Third Quarter 2026 Financial ResultsNasdaq
- SOPHiA GENETICS Reports Third Quarter 2026 ResultsPR Newswire
- Myriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGISNasdaqAZN, MYGN, SOPH
- SOPHiA GENETICS Partners Myriad Genetics To Advance Prostate Genomic Instability Score TechnologyNasdaqMYGN, SOPH
SOPHiA GENETICS SA peers
Technology sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TLSTelos Corporation | 7.26 | -3.84% | $533.85M | vs SOPH |
| PAYSPaysign Inc. | 9.80 | -2.63% | $556.89M | vs SOPH |
| HQHorizon Quantum Holdings Ltd. Class A | 8.94 | -6.19% | $487.73M | vs SOPH |
| GRVYGRAVITY Co. Ltd. American Depository Shares | 69.90 | -3.88% | $485.73M | vs SOPH |
| OOMAOoma Inc. | 16.90 | -0.65% | $466.44M | vs SOPH |
| NRDSNerdWallet Inc. Class A | 7.14 | +1.71% | $452.65M | vs SOPH |
| CARSCars.com Inc. | 12.31 | -0.24% | $641.05M | vs SOPH |
| SHAZSharonAI Holdings Inc. Class A | 16.83 | -18.06% | $647.59M | vs SOPH |
Indexes, lists and sector
Appears in lists
Largest Technology stocks
SOPHiA GENETICS SA stock FAQ
What is SOPHiA GENETICS SA's stock price today?
SOPH last traded at $6.23 as of Nov 20, 4:00 PM EST, down 6.74% on the day. Prices are delayed at least 15 minutes.
Who is SOPHiA GENETICS SA's CEO?
Mr. Ross Jordan Muken B.Sc. is the chief executive officer of SOPHiA GENETICS SA, which has about 415 employees.
What is the SOPH 52-week high?
The 52-week high for SOPH is $8.98 and the 52-week low is $4.01. The stock is currently 30.6% below its high.